NDC properties for "tobramycin (as tobramycin sulfate) 40 MG/ML Injectable Solution" (RxCUI 597823)
About this data
The tables show NDC propoerties for tobramycin (as tobramycin sulfate) 40 MG/ML Injectable Solution with the RxCUI 597823
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tobramycin (as tobramycin sulfate) 40 MG/ML Injectable Solution (RxCUI 597823)
| ANDA | ANDA063111 |
|---|---|
| ANDA | ANDA065013 |
| ANDA | ANDA065120 |
| ANDA | ANDA065122 |
| ANDA | ANDA065407 |
| ANDA | ANDA206965 |
| ANDA | ANDA209346 |
| ANDA | ANDA209621 |
| ANDA | ANDA211189 |
| ANDA | ANDA217029 |
| ANDA | ANDA217519 |
| MMSL_CODE | BD2843 |
| MMSL_CODE | BD2852 |
| MMSL_CODE | CD2843 |
| MMSL_CODE | CD2852 |
| MMSL_CODE | CD2853 |
| MMSL_CODE | CD2860 |
| NDA | NDA050789 |
| RxCUI | 597823 |
| SNOMEDCT | 1237230006 |
| SNOMEDCT | 782122008 |
| SNOMEDCT | 785953004 |
| SPL_SET_ID | 02b48684-168c-4cd9-8375-794206eff23e |
| SPL_SET_ID | 0b4a4b00-7f78-4e95-b870-f88fea73348e |
| SPL_SET_ID | 38219f34-4859-428f-9ec1-06ead7604211 |
| SPL_SET_ID | 49151A62-191A-4BA8-8B8C-BD8535F2FDB3 |
| SPL_SET_ID | 55d09ffd-4f32-8aeb-3904-8a17db635e3a |
| SPL_SET_ID | 645d34d9-275d-428e-863d-ae15ad009c44 |
| SPL_SET_ID | 8b50d1b5-ea8a-5844-358a-493f1965c07f |
| SPL_SET_ID | 8cfeb84f-193a-458a-bdec-205d9274e1a4 |
| SPL_SET_ID | 9a5cecd6-aa65-42d2-b15a-06b4fcebcc0f |
| SPL_SET_ID | a384641c-04e3-4ab5-b152-7408cd07b64d |
| SPL_SET_ID | a9897444-71f6-42af-9b71-4aa77829ade0 |
| SPL_SET_ID | ac8134d9-a726-4508-b8b9-a536ef17243d |
| SPL_SET_ID | c37c251f-92e9-40f0-8b0c-00d42875d776 |
| SPL_SET_ID | c4751a4f-c9c1-60c5-e053-2995a90aeba9 |
| SPL_SET_ID | c5a005b0-7b6f-4e30-df92-9a20b1ca66a1 |
| SPL_SET_ID | d62ff359-912b-4be1-9fc2-2dde8777eefb |
| SPL_SET_ID | d6dd9460-b030-479a-b3e3-03606e6fcad1 |
| SPL_SET_ID | ed254eec-10f4-425a-895b-66e325b7bf69 |
| VUID | 4005550 |
| VUID | 4015256 |
| Prescribable Synonym | tobramycin 40 MG/ML Injectable Solution |
| RXNAV_STR | tobramycin 40 MG/ML Injectable Solution |
| RxNorm Name | tobramycin 40 MG/ML Injectable Solution |
| RxNorm Synonym | tobramycin (as tobramycin sulfate) 40 MG/ML Injectable Solution |
| Related queries | Interactions (for RxCUI 597823) |
NDC Properties
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 00409357801
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-01 |
| NDC Item | 00409357801 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-3578-01) / 2 mL in 1 VIAL, MULTI-DOSE (0409-3578-11) |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 00409357811
| NDC 9 | 0409-3578 |
|---|---|
| NDC 10 | 0409-3578-11 |
| NDC Item | 00409357811 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA063111 |
| Labeler | Hospira, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-05-05 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0409-3578 |
NDC Item 36000024201
| NDC 9 | 36000-242 |
|---|---|
| NDC 10 | 36000-242-01 |
| NDC Item | 36000024201 |
| Packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (36000-242-01) / 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-242 |
NDC Item 36000024401
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-01 |
| NDC Item | 36000024401 |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 36000024425
| NDC 9 | 36000-244 |
|---|---|
| NDC 10 | 36000-244-25 |
| NDC Item | 36000024425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 BLISTER PACK (36000-244-25) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA206965 |
| Labeler | Baxter Healthcare Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2016-07-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 36000-244 |
NDC Item 39822041201
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-1 |
| NDC Item | 39822041201 |
| Packaging | 1 VIAL in 1 CARTON (39822-0412-1) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 39822041206
| NDC 9 | 39822-0412 |
|---|---|
| NDC 10 | 39822-0412-6 |
| NDC Item | 39822041206 |
| Packaging | 6 VIAL in 1 CARTON (39822-0412-6) / 30 mL in 1 VIAL |
| ANDA | ANDA065013 |
| Labeler | XGen Pharmaceuticals DJB, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-08-17 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 39822-0412 |
NDC Item 55150047001
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-01 |
| NDC Item | 55150047001 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 55150047006
| NDC 9 | 55150-470 |
|---|---|
| NDC 10 | 55150-470-06 |
| NDC Item | 55150047006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (55150-470-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (55150-470-01) |
| ANDA | ANDA217519 |
| Labeler | Eugia US LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-06-21 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55150-470 |
NDC Item 63323030301
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-01 |
| NDC Item | 63323030301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030321
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-21 |
| NDC Item | 63323030321 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030351
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-51 |
| NDC Item | 63323030351 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-51) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-01) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030355
| NDC 9 | 63323-303 |
|---|---|
| NDC 10 | 63323-303-55 |
| NDC Item | 63323030355 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-303-55) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-303-21) |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA050789 |
| Related queries | Properties for NDC 9 63323-303 |
NDC Item 63323030601
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-01 |
| NDC Item | 63323030601 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030602
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-02 |
| NDC Item | 63323030602 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-02) / 2 mL in 1 VIAL, MULTI-DOSE (63323-306-01) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030605
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-05 |
| NDC Item | 63323030605 |
| Packaging | 30 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2013-11-19 |
| Marketing effective time low | 2005-11-23 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030626
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-26 |
| NDC Item | 63323030626 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-306-26) / 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030630
| NDC 9 | 63323-306 |
|---|---|
| NDC 10 | 63323-306-30 |
| NDC Item | 63323030630 |
| Packaging | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-306-30) / 30 mL in 1 VIAL, MULTI-DOSE (63323-306-05) |
| ANDA | ANDA065122 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-11-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-306 |
NDC Item 63323030751
| NDC 9 | 63323-307 |
|---|---|
| NDC 10 | 63323-307-51 |
| NDC Item | 63323030751 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA065120 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63323-307 |
NDC Item 67457042800
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-00 |
| NDC Item | 67457042800 |
| Packaging | 30 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457042830
| NDC 9 | 67457-428 |
|---|---|
| NDC 10 | 67457-428-30 |
| NDC Item | 67457042830 |
| Packaging | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-02-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-428 |
NDC Item 67457047300
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-00 |
| NDC Item | 67457047300 |
| Packaging | 2 mL in 1 VIAL |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 67457047322
| NDC 9 | 67457-473 |
|---|---|
| NDC 10 | 67457-473-22 |
| NDC Item | 67457047322 |
| Packaging | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
| ANDA | ANDA065407 |
| Labeler | Mylan Institutional LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-08-19 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 67457-473 |
NDC Item 68083024101
| NDC 9 | 68083-241 |
|---|---|
| NDC 10 | 68083-241-01 |
| NDC Item | 68083024101 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-241-01) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA209346 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-09 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-241 |
NDC Item 68083025401
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-01 |
| NDC Item | 68083025401 |
| Packaging | 2 mL in 1 VIAL, MULTI-DOSE |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083025425
| NDC 9 | 68083-254 |
|---|---|
| NDC 10 | 68083-254-25 |
| NDC Item | 68083025425 |
| Packaging | 25 VIAL, MULTI-DOSE in 1 CARTON (68083-254-25) / 2 mL in 1 VIAL, MULTI-DOSE (68083-254-01) |
| ANDA | ANDA209621 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-02-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-254 |
NDC Item 68083031201
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-01 |
| NDC Item | 68083031201 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 68083031206
| NDC 9 | 68083-312 |
|---|---|
| NDC 10 | 68083-312-06 |
| NDC Item | 68083031206 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (68083-312-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (68083-312-01) |
| ANDA | ANDA211189 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-05-18 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-312 |
NDC Item 70436011036
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-36 |
| NDC Item | 70436011036 |
| Packaging | 30 mL in 1 VIAL (70436-110-36) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011056
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-56 |
| NDC Item | 70436011056 |
| Packaging | 180 mL in 1 CARTON (70436-110-56) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70436011080
| NDC 9 | 70436-110 |
|---|---|
| NDC 10 | 70436-110-80 |
| NDC Item | 70436011080 |
| Packaging | 30 mL in 1 CARTON (70436-110-80) |
| ANDA | ANDA217029 |
| Labeler | Slate Run Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70436-110 |
NDC Item 70700017322
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-22 |
| NDC Item | 70700017322 |
| Packaging | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 70700017386
| NDC 9 | 70700-173 |
|---|---|
| NDC 10 | 70700-173-86 |
| NDC Item | 70700017386 |
| Packaging | 6 CARTON in 1 CARTON (70700-173-86) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Xiromed LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-07-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70700-173 |
NDC Item 72266016301
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-01 |
| NDC Item | 72266016301 |
| Packaging | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72266016306
| NDC 9 | 72266-163 |
|---|---|
| NDC 10 | 72266-163-06 |
| NDC Item | 72266016306 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72266-163-06) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE (72266-163-01) |
| ANDA | ANDA211189 |
| Labeler | Fosun Pharma USA Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-08-11 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-163 |
NDC Item 72603016001
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-01 |
| NDC Item | 72603016001 |
| Packaging | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |
NDC Item 72603016006
| NDC 9 | 72603-160 |
|---|---|
| NDC 10 | 72603-160-06 |
| NDC Item | 72603016006 |
| Packaging | 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (72603-160-06) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| ANDA | ANDA211189 |
| Labeler | Northstar Rx LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-04-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-160 |